Augurix Receives the 2011 Debiopharm /Valais Award

9 Nov 2011

Debiopharm GroupTM, a Swiss-based global biopharmaceutical group with a focus on drug development and companion diagnostics, presents the 2011 ‘Debiopharm /Valais Award’ to Augurix Diagnostics, a privately held company that focuses on point-of-care testing in the field of gastro- enterology and initially on Celiac disease. Debio R.P., the Martigny-based structure of Debiopharm, will award 20’000 Swiss francs to Augurix CEO Thierry Duvanel during the ceremony that will take place on November 10th during the Ark Innovation Day at BioArk center.

Read the press release in English

Read the press release in French

Read the press release in German


Back to the news page »